Fosamprenavir Calcium

福沙那韦钙

Report date: 2026/01/07 17:54:38
NME

Base Information

Drug NameFosamprenavir Calcium
Drug Alias NameFosamprenavirum福司安普那韦钙呋山那韦福沙普利那韦磷氨普那韦 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/10/20
Country/TerritoryCanadaUnited StatesRomania +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesViiv Healthcare
Inactive CompaniesGlaxo Wellcome IncGlaxosmithkline PlcViiv Healthcare Bv +[5] 
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ05AE07
Related LinksWikipediaDrugBankKEGG